tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Financial Statements

Compare
558 Followers

Cogent Biosciences Financial Overview

Cogent Biosciences's market cap is currently $737.75M. The company's EPS TTM is $-2.465; its P/E ratio is ―; Cogent Biosciences is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 7.87M
Gross Profit$ 0.00$ -3.59M$ -5.88M$ -147.00K$ 7.85M
Operating Income$ -275.94M$ -208.13M$ -147.84M$ -75.55M$ -82.20M
EBITDA$ -275.94M$ -205.86M$ -134.36M$ -75.40M$ -34.57M
Net Income$ -255.86M$ -192.41M$ -132.64M$ -71.81M$ -66.45M
Balance Sheet
Cash & Short-Term Investments$ 287.08M$ 265.71M$ 259.28M$ 219.68M$ 242.19M
Total Assets$ 327.90M$ 313.44M$ 300.81M$ 232.09M$ 250.92M
Total Debt$ 17.47M$ 18.85M$ 19.65M$ 3.15M$ 5.21M
Net Debt$ -80.70M$ -34.38M$ -120.24M$ -216.53M$ -236.98M
Total Liabilities$ 71.61M$ 55.63M$ 45.08M$ 17.91M$ 16.25M
Stockholders' Equity$ 256.29M$ 257.80M$ 255.74M$ 214.18M$ 234.67M
Cash Flow
Free Cash Flow$ -207.79M$ -156.42M$ -125.50M$ -60.48M$ -35.85M
Operating Cash Flow$ -207.79M$ -153.62M$ -118.64M$ -58.76M$ -35.85M
Investing Cash Flow$ 38.28M$ -97.82M$ -124.72M$ -1.72M$ 8.42M
Financing Cash Flow$ 214.45M$ 163.54M$ 163.56M$ 37.98M$ 232.20M
Currency in USD

Cogent Biosciences Earnings and Revenue History

Cogent Biosciences Debt to Assets

Cogent Biosciences Cash Flow

Cogent Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis